For a schedule of events for the 2009 Certificate Program, click here.
Venue - Borgia Del Casale
The Borgia Del Casale is a polyfunctional space with great flexibility. Floors in lavic stone, raw stone on vaults and contemporary details contribute to create the ideal location for this year’s Eureka conference. More>>Program overview
Overall Educational Objectives
Participants will:
- Analyze the business, scientific and regulatory aspects of Translational Medicine
- Explore the challenges professionals encounter in Translational Medicine
- Develop critical thinking skills to approach the challenges in Translational Medicine
- Develop communication skills for presenting complex scientific ideas to a broad spectrum of people
- Analyze effective manuscript preparation and begin to apply the concepts to their own work
This innovative international program will provide the opportunity for participants to
experience a variety of novel teaching and learning strategies. Learner-centered
discussions will be integral to the curriculum and all participants will be provided
mentorship with industry leaders and international faculty. A flexible program design will
be tailored to individual needs.
The intensive 7-day program will include case discussions that address key topics and challenges in translational medicine, such as: discovery from basic science (including target validation), securing intellectual property, identifying and validating a translational strategy, preclinical activities (toxicity studies, CMC, IND preparation), clinical trial designs (bioethics, biostatistics, regulatory), and fundraising.
Case studies will be used to facilitate discussion and develop creative problem solving strategies to address the challenges facing drug development today. Participants will have the opportunity to develop novel skills to build new kinds of teams to catalyze the development of drugs.
Hands-on opportunities to hone communication skills will be provided. Through mentorships and elective internships, participants will be able to address their own specific goals.
Participants will receive a certificate of completion of the course. CMEs are currently being sought for the program.
The following International faculty have been confirmed for the May 2009 Conference:
- Salvatore Albani, M.D., Ph.D.
The Charles and Suzanne Stephen’s Chair and Director for the Arizona Arthritis Center, The University of Arizona - Juan Carlos Lopez, Ph.D.
Editor in Chief, Nature Medicine - Dirk Elewaut, M.D.
University Hospital, Department of Rheumatology, Laboratory of Molecular Immunology and Inflammation - Wainwright Fishburn, J.D.
Partner, Cooley Godward Kronish LLP - Carol Gregorio, Ph.D.
Professor of Cell Biology and Anatomy, The University of Arizona - David Hafler, M.D., Ph.D.
Breakstone Professor of Neurology (Neuroscience), Harvard Medical School; Physician, Brigham and Women’s Hospital and Massachusetts General Hospital in Boston - Janet Hafler, Ed.D.
Visiting professor at Tufts University; Educational Consultant - Jesse Hall, M.D.
Associate Medical Director, Rheumatology Medical Affairs, Immunology Development, Abbott Laboratories - Paul Krieg, Ph.D.
Professor of Cell Biology and Anatomy and Molecular and Cellular Biology, The University of Arizona - Jim Margolis, M.B.A.
Senior Partner, GMMB. Advisor, Obama Presidential Campaign - Martin Offringa, M.D., Ph.D.
Professor and Head, Department of Pediatric Clinical Epidemiology; Staff member, Department of Neonatology, Emma Children's Hospital, Academic Medical Center, University of Amsterdam; Director, Netherlands Medicines for Children Research Network; Chair, International Forum for Standards for Research with Children www.STaRChildHealth.org; Co-Director, Dutch National Pediatric Pharmacotherapy Expertise Network, www.nkfk.nl; Co-Editor in chief, Evidence-Based Child Health: a Cochrane Review Journal, www.evidence-basedchildhealth.com - Berent Prakken, M.D., Ph.D.
Professor of Pediatric Immunology at the University Medical Centre Utrecht, the Netherlands; Chair, EULAR - Maria Grazia Roncarolo, M.D., Ph.D.
Scientific Director, San Raffaele Scientific Institute; Professor of Pediatrics, School of Medicine and Surgery, San Raffaele Vita-Salute University; Chief of Clinic, Pediatric Immunology and Hematology and Clinical Research Unit (CRU-P) San Raffaele Hospital and San Raffaele Scientific Institute, Milan, Italy - Norm Rosenblum, M.D.
Professor of Paediatrics, Canada Research Chair in Developmental Nephrology, and Director of Clinician Scientist Training Programs, University of Toronto - Vicki Seyfert-Margolis, Ph.D.
Chief Scientific Officer, Immune Tolerance Network
Our International faculty and speakers will deliver lectures and keynote speeches on the following topics:
- Bridging the worlds of Academia and Industry
- Bridging the translational divide: Project planning and building dynamic teams
- The art of startup: developing and securing intellectual property
- Biological and clinical outcomes in trials
- Defining trial success
- Discourse, diatribe and dialogue: the keys to effective communication
- In print, the mysteries of publication
- Transcending international borders in academic ventures
- Product development in Large Pharma
- IND (tentative)
- From molehills to mountains: transforming basic research into leads
- Interfacing academia and industry